Thiobarbital
Thiobarbital
|
Clinical data |
---|
Pregnancy category |
|
---|
Routes of administration |
? |
---|
ATC code |
?? (WHO) |
---|
Legal status |
---|
Legal status |
|
---|
Pharmacokinetic data |
---|
Bioavailability |
? |
---|
Metabolism |
? |
---|
Biological half-life |
? |
---|
Excretion |
? |
---|
Identifiers |
---|
- 5,5-diethyl-2-thioxodihydropyrimidine-4,6(1H,5H)-dione
|
CAS Number |
77-32-7 N |
---|
PubChem (CID) |
667509 |
---|
DrugBank |
? N |
---|
ChemSpider |
580885 Y |
---|
ECHA InfoCard |
100.000.929 |
---|
Chemical and physical data |
---|
Formula |
C8H12N2O2S |
---|
Molar mass |
200.259 |
---|
3D model (Jmol) |
Interactive image |
---|
|
InChI=1S/C8H12N2O2S/c1-3-8(4-2)5(11)9-7(13)10-6(8)12/h3-4H2,1-2H3,(H2,9,10,11,12,13) YKey:QGVNJRROSLYGKF-UHFFFAOYSA-N Y
|
NY (what is this?) (verify) |
---|
Thiobarbital is a drug which is a barbiturate derivative. It is the thiobarbiturate analogue of barbital.
Synthesis
It is of note that although the drug can be prepared by the above route (cf eg thialbarbital), rxn of barbital with phosphorus pentasulfide constitutes an alternative route to thiobarbital.
References
- ↑ Fischer, E.; Dilthey, A. (1904). "Ueber C-Dialkylbarbitursäuren und über die Ureïde der Dialkylessigsäuren". Justus Liebig's Annalen der Chemie. 335 (3): 334. doi:10.1002/jlac.19043350303.
- ↑ Carrington, H. C. (1944). "45. The action of phosphorus pentasulphide on barbituric acids". Journal of the Chemical Society (Resumed): 124. doi:10.1039/JR9440000124.
|
---|
|
Alcohols | |
---|
|
Barbiturates | |
---|
|
Benzodiazepines | |
---|
|
Carbamates | |
---|
|
Flavonoids | |
---|
|
Imidazoles | |
---|
|
Kava constituents |
- 10-Methoxyyangonin
- 11-Methoxyyangonin
- 11-Hydroxyyangonin
- Desmethoxyyangonin
- 11-Methoxy-12-hydroxydehydrokavain
- 7,8-Dihydroyangonin
- Kavain
- 5-Hydroxykavain
- 5,6-Dihydroyangonin
- 7,8-Dihydrokavain
- 5,6,7,8-Tetrahydroyangonin
- 5,6-Dehydromethysticin
- Methysticin
- 7,8-Dihydromethysticin
- Yangonin
|
---|
|
Monoureides | |
---|
|
Neuroactive steroids | |
---|
|
Nonbenzodiazepines | |
---|
|
Phenols | |
---|
|
Piperidinediones | |
---|
|
Pyrazolopyridines | |
---|
|
Quinazolinones | |
---|
|
Volatiles/gases | |
---|
|
Others/unsorted |
- 3-Hydroxybutanal
- α-EMTBL
- AA-29504
- Avermectins (e.g., ivermectin)
- Bromide compounds (e.g., lithium bromide, potassium bromide, sodium bromide)
- Carbamazepine
- Chloralose
- Chlormezanone
- Clomethiazole
- DEABL
- Dihydroergolines (e.g., dihydroergocryptine, dihydroergosine, dihydroergotamine, ergoloid (dihydroergotoxine))
- DS2
- Efavirenz
- Etazepine
- Etifoxine
- Fenamates (e.g., flufenamic acid, mefenamic acid, niflumic acid, tolfenamic acid)
- Fluoxetine
- Flupirtine
- Hopantenic acid
- Lanthanum
- Lavender oil
- Lignans (e.g., 4-O-methylhonokiol, honokiol, magnolol, obovatol)
- Loreclezole
- Menthyl isovalerate (validolum)
- Monastrol
- Niacin
- Nicotinamide (niacinamide)
- Org 25,435
- Phenytoin
- Propanidid
- Retigabine (ezogabine)
- Safranal
- Seproxetine
- Stiripentol
- Sulfonylalkanes (e.g., sulfonmethane (sulfonal), tetronal, trional)
- Terpenoids (e.g., borneol)
- Topiramate
- Valerian constituents (e.g., isovaleric acid, isovaleramide, valerenic acid, valerenol)
- Unsorted benzodiazepine site PAMs: MRK-409 (MK-0343)
- TCS-1105
- TCS-1205
|
---|
|
See also: GABAergics |